Abstract: The disclosure describes compounds of formula I, wherein the wedged bonds, R1, R2, R3, R4, R5, R5a, R6, R7, R8, R9, R10, R11, R12, R13, R14, X and Y have meanings given in the description, and pharmaceutically-acceptable salts thereof; and methods of using such compounds useful in the treatment of cancer and conditions affected by inhibition of angiogenesis. Also provided, are processes for the preparation of formula I, by reacting formula I with other compounds; and processes for the preparation of a pharmaceutical formulation by bringing into association, a compound of formula I, with therapeutic agents and/or a pharmaceutically-acceptable adjuvant, diluent, or carrier.

Abstract: There is provided a dual-polarized N/2-column antenna arrangement. The antenna module arrangement comprises a coupler module. The coupler module is arranged to direct a first summation of energy from signals from a first distinct set of power amplifiers of an N-channel radio to a first single output port connected to a first polarization of a first column of the dual-polarized N/2-column antenna arrangement. The coupler module is arranged to direct a second summation of energy from signals from a second distinct set of power amplifiers of the N-channel radio to a second single output port connected to a second polarization of a second column of the dual-polarized N/2-column antenna arrangement.

Abstract: A drill guide for installing an implant in a blind hole in a bone under a soft tissue is disclosed. The drill guide includes a cylindrical portion that includes a cylindrical canal extending along a longitudinal axis of the cylindrical portion. The cylindrical canal is adapted to receive a drill member for drilling the blind hole in the bone. The drill guide further includes a flange at a proximal end section of the drill guide. The drill guide extends perpendicular or substantially perpendicular to the longitudinal axis of the cylindrical portion. The drill guide has a length that is equal or greater than thickness of the soft tissue. A distal end of the drill guide, when inserted in a hole, is adapted to rest against a bone surface that interfaces with the soft tissue.

Abstract: The present invention provides a process for lowering the amount of esters of 2- and 3-MCPD in refined triglyceride oil, wherein said oil prior to entering the process has been treated with one or more refining steps and wherein said oil comprises triglycerides of fatty acids having a carbon chain length of C12-C24 in an amount of at least 50% of the total triglyceride content, the process comprising the steps of: blending the oil with a base and heat treating the oil while passing steam through the oil at reduced pressure, keeping the degree of interesterification in the product from the process below 60%.

Abstract: The present disclosure provides a dental bridge intermediary structure (20) comprising a superstructure (200) and a connection piece (210), as well as connection piece for a dental bridge intermediary structure (20). A method for producing a dental bridge superstructure (200) is also provided.

Abstract: The present invention relates to an antenna arrangement (100) comprising an antenna part comprising at least two antenna means, each with a number of first antenna elements having a first polarization and a number of second antenna elements having a second polarization different from said first polarization, said antenna part further comprising antenna part ports. There are two antenna part ports for each antenna means, one antenna part port for each polarization, and the antenna arrangement (100) further comprises polarization controlling means (30), comprising a distribution network, to which the antenna part ports are connected, and which includes at least a main forming network with external interface antenna ports (301,302,303,304). The polarization controlling means (30) is configured to connect antenna part ports and external interface antenna ports (301, 302, 303, 304).

Abstract: The present invention relates to a communication node (1) comprising at least one antenna arrangement (2) with two horizontal and two vertical array antennas. A first horizontal antenna port (4) and a second vertical antenna port (10) are connected to a first polarization (P1). A first vertical antenna port (8) and a second horizontal antenna port (6) are connected to an orthogonal second polarization (P2). Each port is connected to corresponding antenna elements. Said first horizontal antenna port (4) and said first vertical antenna port (8) are connected in phase. Said second horizontal antenna port (6) and said second vertical antenna port (10) are connected with opposite phases. A plurality of antenna element symmetry pairs (11a, 12a; 11b, 12b; 11c, 12c; 11d, 12d; 13a, 14a; 13b, 14b; 13c, 14c; 13d, 14d) are formed with respect to a common symmetry point (15).

Abstract: Compounds and a method for imaging myocardial perfusion, including administering to a patient a compound linked to an imaging moiety, wherein the compound binds MC-1, and scanning the patient using diagnostic imaging. Kits including the compound or precursor compounds linked or not linked to an imaging moiety are also described.

Abstract: A signal combiner for combining transmission signals to be supplied to four antennas devices, wherein two of the antenna devices are polarized in a first orientation and two of the antenna devices are polarized in a second orientation essentially orthogonal to the first orientation. The signal combiner comprises: four input connections arranged to receive the transmission signals; four output connections arranged to drive a respective one of the four of antenna devices using respective output signals. The signal combiner is arranged to combine transmission signals supplied on each input connection to all of the four output connections using beam forming and phase adjustment, such that, in use, each supplied transmission signal generates a central beam polarized in the first orientation and a side beam polarized in the second orientation. It is also presented a corresponding method, computer program and computer program product.

Abstract: An implant for percutaneous implantation through the abdominal wall for encircling and engaging an externalized length of a body duct of a human or animal patient. The implant has an exterior tubular section defined by an circumferential exterior wall at least a part of which is adapted to protrude outwardly from the abdominal wall with a free end for mounting of a detachable device, an interior section defined by an circumferential interior wall adapted to extend through the abdominal wall and inside the patient for internal fixation of the implant, wherein the exterior tubular section and the interior section have a common axis A.

Abstract: The disclosure describes compounds of formula I, wherein the wedged bonds, R1, R2, R3, R4, R5, R5a, R6, R7, R8, R9, R10, R11, R12, R13, R14, X and Y have meanings given in the description, and pharmaceutically-acceptable salts thereof; and methods of using such compounds useful in the treatment of cancer and conditions affected by inhibition of angiogenesis. Also provided, are processes for the preparation of formula I, by reacting formula I with other compounds; and processes for the preparation of a pharmaceutical formulation by bringing into association, a compound of formula I, with therapeutic agents and/or a pharmaceutically-acceptable adjuvant, diluent, or carrier.

Abstract: The disclosure describes compounds of formula I, wherein the wedged bonds, R1, R2, R3, R4, R5, R5a, R6, R7, R8, R9, R10, R11, R12, R13, R14, X and Y have meanings given in the description, and pharmaceutically-acceptable salts thereof; and methods of using such compounds useful in the treatment of cancer and conditions affected by inhibition of angiogenesis. Also provided, are processes for the preparation of formula I, by reacting formula I with other compounds; and processes for the preparation of a pharmaceutical formulation by bringing into association, a compound of formula I, with therapeutic agents and/or a pharmaceutically-acceptable adjuvant, diluent, or carrier.

Abstract: The present invention relates to a node in a wireless communication system, the node comprising at least a first, a second and a third antenna function. A first and second downlink signal, and a first and second uplink signal are transferred via said antenna functions, which together form a first total antenna function and a second total antenna function. The first and second downlink signals are transferred via the first total antenna function, and the first and second uplink signal are transferred via the second total antenna function. The second downlink signal and the second uplink signal are transferred via a common connection connected to a filter means which is arranged for separating these signals to connect them to different antenna functions. The present invention also relates to a corresponding method.

Abstract: A wireless communication system comprising at least one base station in a communication cell, wherein the base station is equipped with at least one array antenna comprising at least two antenna ports which are connected to respective at least two corresponding antenna elements, wherein at least two of the at least two antenna elements have essentially the same polarization. The array antenna is arranged for communication via at least two antenna radiation lobes, each antenna radiation lobe communicating an information stream to at least one user equipment (UE) in the cell, wherein each antenna radiation lobe is individually controllable both in azimuth and elevation, whereby the communication of the information streams is optimized.

Abstract: The present disclosure provides a dental bridge intermediary structure (20) comprising a superstructure (200) and a connection piece (210), as well as connection piece for a dental bridge intermediary structure (20). A method for producing a dental bridge superstructure (200) is also provided.

Abstract: A network controller as well as a method in a network controller for coordinating resource assignments to radio access points of a superdense, SDN, network is provided. The method comprises identifying a set of radio access points in the SDN network whose respective radio resource assignment is to be independently coordinated. The method also comprises obtaining interference information indicative of the extent to which radio transmissions to or from different radio access points in the set would interfere with one another absent radio resource assignment coordination. The method then forms subsets of the radio access points in the set based on this obtained interference information. The method also assigns different subsets of radio resources to the different subsets of the radio access points, and reports assignment information to the radio access points in the set, indicating the assignment of radio resources.

Abstract: It is presented a signal combiner for combining transmission signals to foe supplied to four antennas devices, wherein two of the antenna devices are polarised in a first orientation and two of the antenna devices are polarised in a second orientation essentially orthogonal to the first orientation. The signal combiner comprises: four input connections arranged to receive the transmission signals; four output connections arranged to drive a respective one of the four of antenna devices using respective output signals. The signal combiner is arranged to combine transmission signals supplied on each input connection to all of the four output connections using beam forming and phase adjustment, such that, in use, each supplied transmission signal generates a central beam polarised in the first orientation and a side beam polarised in the second orientation, It is also presented a corresponding method, computer program and computer program product.

Abstract: A percutaneous ostomy implant for implantation into the abdominal wall of a patient is provided, which includes a connecting member for mounting an external detachable device thereto; a first tubular ingrowth member depending from the connecting member; and a second tubular ingrowth member depending from the connecting member and being radially outwardly spaced from the first tubular ingrowth member. The first tubular ingrowth member is configured and dimensioned to receive a bowel segment within it to allow the stoma and serosal tissue of that bowel segment to infiltrate the first tubular ingrowth member. The second tubular member is configured and dimensioned to abut dermal tissue to allow the dermal tissue to infiltrate the second tubular ingrowth member, thereby securing and sealing the ostomy implant to the dermis.

Abstract: An implant for percutaneous implantation through the abdominal wall for encircling and engaging an externalized length of a body duct of a human or animal patient. The implant has an exterior ring section protruding outwardly from the abdominal wall with a free end which serves for mounting of a detachable device, and an interior section extending through the abdominal wall and inside the patient for internal fixation of the implant. The exterior ring section and interior section have a common axis. The internal circumference of at least a part of the exterior ring section above the interior section is arranged with a biocompatible, integrated ingrowth means for the exterior surface of the body duct wall.